Mrs
Ellie
Purnell

Patent Director

Manchester Office

Life sciences

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Ellie is a UK and European qualified patent attorney with a strong academic background in Life Sciences, particularly in Plant Sciences. In addition, Ellie holds a qualification as a Patent Attorney Litigator with advocacy experience working on oppositions and appeals before the European Patent Office. She specialises in dealing with technology in the Gene Editing, Antibody, Peptide, AgBio, and Microbiology fields. Ellie is interested in helping SMEs, start-ups and spin-outs maximise their potential by exploiting IP protection and good IP management. She enjoys working with challenging IP portfolios and developing IP strategies. In particular for those cases experiencing difficulty in European prosecution.

Ellie has worked with all types of clients, from multinational companies including AstraZeneca, Novartis, and Dow AgroSciences, to small start ups and spin outs such as Pepgen and Tissue Regenix.

Qualifications

Patent Attorney

Chartered (UK)
Europe


MA

(Cantab) Natural Sciences - Double First Class Honours

POSTGRADUATE DIPLOMA OR CERTIFICATE

Intellectual Property Litigation and Advocacy Certificate - Nottingham Trent University - Distinction

Recognition

Senior Scholar and Honarary Senior Scholar of Gonville & Caius College, Cambridge

Awarded to undergraduates who achieved a first class in university examinations, achieved in 2009 and 2010

The Frank Smart Prize for Botany

Awarded to undergraduate who achieved highest overall marks in Plant Sciences, awarded in 2009 and 2010

The Keith Farewell Prize

Awarded by CIPA to the patent trainee who achieved the highest mark in the P7 examination (UK trademark law)

Publications

CRISPR Edited T cells win the TvT Battle

View publication online

Patenting antibodies in the US and Europe

View publication online

The EPO ‘How To’ guide for antibody applications in Europe

View publication online

AI solution to Levinthal's paradox

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

A look at the WIPO coronavirus tools

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

G3/19: An end to the saga…

View publication online

G3/19: A further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

G3/19: A Further Referral to the Enlarged Board of Appeal on Plants Produced by Essentially Biological Processes

View publication online

Compulsory licences: the key to accessing inventions in the face of coronavirus?

View publication online

A look at the WIPO coronavirus tools

View publication online

IP considerations in COVID-19 vaccine development: tensions and tools

View publication online

How a platform technology patent list can expedite covid-19 vaccine research

View publication online

The Patent Landscape Behind COVID-19 Vaccines

View publication online

Conferences: 2022

September 22nd 2022

BioCap Conference 2022

Attended

Event details

Conferences: 2021

July 2nd 2021

G1/21 hearing at the EPO - July

Attended

Event details

January 7th 2021

iBioIC

Attended

Event details

Conferences: 2020

November 4th 2020

Bionow Oncology Conference 2020

Attended

Event details

CSR

Ellie regularly holds tutorials for trainees within HGF, and has acted as an ongoing mentor for those trainees taking UK finals examinations.

She has also recently acted as a CIPA designated mentor for candidates re-taking the UK law exam (FD1).

In the past, Ellie held the position of the Northern Informals Secretary for several years organising social and educational events for trainees across the North of England, including organising and implementing a series of tutorials with tutors from different firms.

Related News

From Theoretical Proposals to Commercial Reality: The Rise of Innovation and Patent Filings in Quantum Computing

The possibility of quantum computing was first seriously proposed in the early 1980s and is widely regarded as having enormous potential to deliver a step change in the complexity of …

Read article
Event - 3rd February 2023

The European Patent Office are running an inspiring collaborative art competition for children

To celebrate the 50th anniversary of the signing of the European Patent Convention, The European Patent Office (EPO) is running a collaborative art competition for primary schools on the topic …

Event details
Event - 8th-9th February 2023

5th Annual Microbiome & Probiotic Conference 2023

The 5th Annual MarketsandMarkets Next Gen Microbiome and Probiotics Conference will take place in San Diego on the 8th-9th of February. This conference will enable you to learn about microbial …

Event details
Event - 17th January 2023

CIPA Webinar: Enhancing Diversity in the Patent Profession How Can I Help

CIPA hosted a webinar to discuss ‘Enhancing diversity in the patent profession.’ Date Tuesday 17 January, 2023 Time 12.30pm – 1.30pm (GMT) Equity, diversity and inclusion has been in the …

Event details

LiDAR: A Significant Support Technology at CES

When visiting CES’ one thing that struck me was the number of companies demonstrating LiDAR technology. LiDAR has been around since the 1960s and was originally developed for aerospace use, …

Read article

Healthcare and Climate Change

Can we find a balance between intellectual property rights and public health needs when tackling the climate crisis? “The world faces a critical juncture. A health-centred, aligned response to the …

Read article

Navigating the CRISPR IP confusion

It is just over 10 years since the Science publication of Jinek et al. showed for the first time that DNA cleavage could be achieved in vitro with a Cas9 …

Read article

CRISPR Edited T cells win the TvT Battle

T-cells which have been modified using CRISPR base editing technology have been successfully used to treat T-cell acute lymphoblastic leukaemia for the first time {1}. A 13 year old patient …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.